1313 related articles for article (PubMed ID: 1681365)
1. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
[TBL] [Abstract][Full Text] [Related]
2. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.
Levine MM; Ferreccio C; Cryz S; Ortiz E
Lancet; 1990 Oct; 336(8720):891-4. PubMed ID: 1976928
[TBL] [Abstract][Full Text] [Related]
3. Vaccines for preventing typhoid fever.
Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
[TBL] [Abstract][Full Text] [Related]
4. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation.
Levine MM; Ferreccio C; Black RE; Germanier R
Lancet; 1987 May; 1(8541):1049-52. PubMed ID: 2883393
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee.
Black RE; Levine MM; Ferreccio C; Clements ML; Lanata C; Rooney J; Germanier R
Vaccine; 1990 Feb; 8(1):81-4. PubMed ID: 2180234
[TBL] [Abstract][Full Text] [Related]
6. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.
Levine MM; Ferreccio C; Abrego P; Martin OS; Ortiz E; Cryz S
Vaccine; 1999 Oct; 17 Suppl 2():S22-7. PubMed ID: 10506405
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules.
Black R; Levine MM; Young C; Rooney J; Levine S; Clements ML; O'Donnell S; Hugues T; Germanier R
Dev Biol Stand; 1983; 53():9-14. PubMed ID: 6307787
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for preventing typhoid fever.
Milligan R; Paul M; Richardson M; Neuberger A
Cochrane Database Syst Rev; 2018 May; 5(5):CD001261. PubMed ID: 29851031
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Lundgren A; Sack DA; Svennerholm AM; Qadri F
Vaccine; 2014 Feb; 32(9):1055-60. PubMed ID: 24440210
[TBL] [Abstract][Full Text] [Related]
10. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046
[TBL] [Abstract][Full Text] [Related]
11. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
12. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for preventing typhoid fever.
Fraser A; Goldberg E; Acosta CJ; Paul M; Leibovici L
Cochrane Database Syst Rev; 2007 Jul; (3):CD001261. PubMed ID: 17636661
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
15. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
[TBL] [Abstract][Full Text] [Related]
16. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564
[TBL] [Abstract][Full Text] [Related]
17. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
18. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
Wahid R; Fresnay S; Levine MM; Sztein MB
Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480
[TBL] [Abstract][Full Text] [Related]
19. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area.
Ferreccio C; Levine MM; Rodriguez H; Contreras R
J Infect Dis; 1989 Apr; 159(4):766-9. PubMed ID: 2647863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
